Reliability of High-Alert Medications Questionnaire in Turkish Healthcare Professionals

被引:0
|
作者
Ozturk, Feyza [1 ]
Altiparmak, Oznur [2 ]
Torun, Beyza [1 ]
Bektay, Muhammed Yunus [1 ]
Sancar, Mesut [1 ]
Okuyan, Betul [1 ]
机构
[1] Marmara Univ, Dept Clin Pharm, Fac Pharm, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Dept Clin Pharm, Fac Pharm, Istanbul, Turkey
来源
BEZMIALEM SCIENCE | 2022年 / 10卷 / 01期
关键词
High-risk medication; healthcare professional; medication safety; pharmacist; nurse; knowledge; NURSES KNOWLEDGE; PRESCRIPTION; INSTRUMENT;
D O I
10.14235/bas.galenos.2020.5238
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to evaluate the reliability of the High Alert Medications (HAM) Questionnaire in Turkish healthcare professionals. Methods: This methodological study was conducted between December 2017 and January 2018 in a private university hospital. The healthcare professionals, including nurses, health service technicians, and pharmacists, who are older than 18 years old were eligible for this study. After following the appropriate translation and cultural adaptation process, the internal consistency of the HAM Questionnaire using the Kuder-Richardson 20 coefficient and test-retest reliability was evaluated. Results: Among 146 healthcare professionals, the mean age was 25.40 +/- 5.16 years, wherein 76% were females. Most participants were nurses (69.9%) and other healthcare professionals were health service technicians (28.1%) and pharmacists (2.0%). The mean total score of the HAM Questionnaire was 70.00 +/- 19.50. The KuderRichardson 20 was 0.815. A statistically significant correlation was found between the scores of the HAM Questionnaire at baseline and after 15 days, which confirmed the test-retest reliability (r=0.527; p<0.01). A statistically significant correlation was found between the HAM Questionnaire score and advanced age (r=0.310; p<0.001) and higher professional year (r=0.445; p<0.001). Conclusion: The Turkish version of the HAM Questionnaire could be used to assess healthcare professionals' knowledge about high-alert medications.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 50 条
  • [1] The reliability and validity study of Turkish Version of High Alert Medications Knowledge Questionnaire
    Okuyan, B.
    Ozkan, O.
    Torun, B.
    Ozturk, F.
    Sancar, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 318 - 318
  • [2] The Experience of Management of High-Alert Medications
    Peng, Tzu Rong
    Wu, Ta Wei
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2017, 32 (05) : 571 - 571
  • [3] High-alert medications in the PICU.
    Franke, Hillary A.
    Woods, Donna M.
    Holl, Jane L.
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (12) : A125 - A125
  • [4] High-alert medications in pediatrics hospital
    Bataille, J.
    Joret, P.
    Prot-Labarthe, S.
    Bourdon, O.
    Brion, F.
    Hartmann, J. -F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1321 - 1321
  • [6] Errors in hospital prescriptions of high-alert medications
    Rosa, Mario Borges
    Perini, Edson
    Anacleto, Tania Azevedo
    Neiva, Hessem Miranda
    Bogutchi, Tania
    [J]. REVISTA DE SAUDE PUBLICA, 2009, 43 (03):
  • [7] High-Alert Medications: Strategies for Improving Safety
    Ebright, Patricia
    [J]. CLINICAL NURSE SPECIALIST, 2009, 23 (03) : 177 - 177
  • [8] Preventing Harm from High-Alert Medications
    Federico, Frank
    [J]. JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2007, 33 (09): : 537 - 542
  • [9] Pediatric High-Alert Medications: Evidenced-Based Safe Practices for Nursing Professionals
    Faber, RoseMarie
    [J]. CRITICAL CARE NURSE, 2009, 29 (01) : 88 - 88
  • [10] How to Identify Organizational High-Alert Medications
    Schepel, Lotta
    Lehtonen, Lasse
    Airaksinen, Marja
    Lapatto-Reiniluoto, Outi
    [J]. JOURNAL OF PATIENT SAFETY, 2021, 17 (08) : E1358 - E1363